Clinical practice guidelines for dysphagia management in intensive care unit: a speech-language pathologist’s framework
Abstract
Objective: This study aims at assessing the feasibility of the involvement of speech language pathologists in the identification and intervention of dysphagia in ICU patients. This brings the need of making a comparison of the procedures and using of diagnostic instruments like the FEES and VFSS. The goal of the study is to assess the effects of early identification and assessment of aspiration pneumonia, to explore available therapeutic options like NMES and postural adjustments, as well as to determine how integrated interprofessional approach can help to improve the quality of dysphagia management within the ICU population. Methods: The development of Clinical Practice Guideline (CPG) was done with the assistance of a development committee and advisory committee. The CPG development group comprised three Neurophysicians, three Otolaryngologists, three Nurses and four Speech-Language Pathologists (SLPs). It was agreed that all members contributed to the identification of the evidence to be presented and deliberation of the recommendations in response to the Key Questions (KQs) to ensure that the guideline formulated is holistic and evidence based for use in the ICU in managing dysphagia. Then Literature review was done by an extensive search of papers using some of the most popular search databases including; Pubmed, Embase, and the Cochrane library. Specifically, research with patients in an adult ICU was considered and considered to be meeting inclusion criteria.…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.